Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Cochlear implants (CIs) have revolutionized how we treat hearing impairment. Despite major technological and clinical advances, some CI children's language abilities remain below those of their age-matched peers, and there is still considerable individual variability in final outcomes. One important factor underlying this may be individual differences in brain plasticity before and after implantation. However, the neural changes induced in the developing brain by deafness, language deprivation, and the restoration of hearing due to implantation are little understood, in part because the methodological options available are limited. Recently, functional near-infrared spectroscopy (fNIRS) has emerged as a fully CI-compatible, infant-friendly, non-invasive, and inexpensive technique that holds the promise of shedding light on the neural mechanisms accompanying deafness and CI use. Here, we review the existing fNIRS studies with developmental populations. We then discuss the methodological challenges that using fNIRS with CI children raise. Finally, we describe open questions that fNIRS has the potential to answer. We conclude that fNIRS is a powerful tool to investigate the neural mechanisms and changes brought about by deafness and the subsequent restoration of hearing with CI.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12330856PMC
http://dx.doi.org/10.1162/IMAG.a.90DOI Listing

Publication Analysis

Top Keywords

developing brain
8
near-infrared spectroscopy
8
restoration hearing
8
neural mechanisms
8
fnirs
5
imaging developing
4
brain near-infrared
4
spectroscopy cochlear
4
cochlear implanted
4
implanted children
4

Similar Publications

Spinal muscular atrophy (SMA) is a neuromuscular disease caused by low levels of SMN protein. Several therapeutic approaches boosting SMN are approved for human patients, delivering remarkable improvements in lifespan and symptoms. However, emerging phenotypes, including neurodevelopmental comorbidities, are being reported in some treated SMA patients, indicative of alterations in brain development.

View Article and Find Full Text PDF

Recessive TMEM167A variants cause neonatal diabetes, microcephaly and epilepsy syndrome.

J Clin Invest

September 2025

Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, United Kingdom.

Understanding the genetic causes of diseases affecting pancreatic β cells and neurons can give insights into pathways essential for both cell types. Microcephaly, epilepsy and diabetes syndrome (MEDS) is a congenital disorder with two known aetiological genes, IER3IP1 and YIPF5. Both genes encode proteins involved in endoplasmic reticulum (ER) to Golgi trafficking.

View Article and Find Full Text PDF

Neural stem cells (NSCs) are multipotent stem cells with self-renewal capacity, able to differentiate into all neural lineages of the central nervous system, including neurons, oligodendrocytes, and astrocytes; thus, their proliferation and differentiation are essential for embryonic neurodevelopment and adult brain homoeostasis. Dysregulation in these processes is implicated in neurological disorders, highlighting the need to elucidate how NSCs proliferate and differentiate to clarify the mechanisms of neurogenesis and uncover potential therapeutic targets. MicroRNAs (miRNAs) are small, post-transcriptional regulators of gene expression involved in many aspects of nervous system development and function.

View Article and Find Full Text PDF

Retinal ganglion cells (RGCs) are highly compartmentalized neurons whose long axons serve as the sole connection between the eye and the brain. In both injury and disease, RGC degeneration occurs in a similarly compartmentalized manner, with distinct molecular and cellular responses in the axonal and somatodendritic regions. The goal of this study was to establish a microfluidic-based platform to investigate RGC compartmentalization in both health and disease states.

View Article and Find Full Text PDF

Purpose: Breast cancer (BC) is the most frequent cancer among women and the second leading cause of central nervous system (CNS) metastases. While the epidemiology of CNS metastases from BC has been well described, little is known about the treatment patterns and outcomes of young women < 40 years of age with BC that is metastatic to the CNS.

Methods: In this retrospective analysis, we identified patients with metastatic breast cancer (MBC) to the CNS who were treated at the Sunnybrook Odette Cancer Center, Toronto, Canada between 2008 and 2018.

View Article and Find Full Text PDF